Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-5-24
pubmed:abstractText
To describe the biochemical failure-free survival (BFFS), GU toxicity and erectile dysfunction in intermediate risk prostate cancer treated with iodine 125 monotherapy (I125).
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1769-6658
pubmed:author
pubmed:copyrightInfo
2010 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
183-8
pubmed:meshHeading
pubmed-meshheading:20418145-Adenocarcinoma, pubmed-meshheading:20418145-Aged, pubmed-meshheading:20418145-Antineoplastic Agents, Hormonal, pubmed-meshheading:20418145-Brachytherapy, pubmed-meshheading:20418145-Combined Modality Therapy, pubmed-meshheading:20418145-Disease-Free Survival, pubmed-meshheading:20418145-Erectile Dysfunction, pubmed-meshheading:20418145-Follow-Up Studies, pubmed-meshheading:20418145-Humans, pubmed-meshheading:20418145-Iodine Radioisotopes, pubmed-meshheading:20418145-Male, pubmed-meshheading:20418145-Middle Aged, pubmed-meshheading:20418145-Prostate-Specific Antigen, pubmed-meshheading:20418145-Prostatic Neoplasms, pubmed-meshheading:20418145-Quebec, pubmed-meshheading:20418145-Radiation Injuries, pubmed-meshheading:20418145-Retrospective Studies, pubmed-meshheading:20418145-Risk, pubmed-meshheading:20418145-Treatment Outcome, pubmed-meshheading:20418145-Urination Disorders
pubmed:year
2010
pubmed:articleTitle
[Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience].
pubmed:affiliation
Département de radiothérapie, CHUQ Hôtel-Dieu, Côte-du-Palais, QC, Canada.
pubmed:publicationType
Journal Article, English Abstract, Evaluation Studies